Results 231 to 240 of about 2,733,894 (315)
Bearing-based localization for leader-follower formation control. [PDF]
Han Q, Ren S, Lang H, Zhang C.
europepmc +1 more source
Phase formation control in plasma sprayed alumina-chromia coatings
J. Dubský +4 more
openalex +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
Leader-Follower Formation Control of UUVs with Model Uncertainties, Current Disturbances, and Unstable Communication. [PDF]
Yan Z, Xu D, Chen T, Zhang W, Liu Y.
europepmc +1 more source
A Guidance and Control Law for Autonomous Formation of Quadrotors
Xun Zhu, Shuguang Zhang
openalex +1 more source
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Joint Formation Control with Obstacle Avoidance of Towfish and Multiple Autonomous Underwater Vehicles Based on Graph Theory and the Null-Space-Based Method. [PDF]
Pang SK, Li YH, Yi H.
europepmc +1 more source
Formation of organelle-like N 2 -fixing symbiosomes in legume root nodules is controlled by DMI2
Erik Limpens +6 more
openalex +2 more sources
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source

